Sunitinib for metastatic progressive phaeochromocytomas and paragangliomas: results from FIRSTMAPPP, an academic, multicentre, international, randomised, placebo-controlled, double-blind, phase 2 trial
- Resource Type
- Article
- Source
- The Lancet; March 2024, Vol. 403 Issue: 10431 p1061-1070, 10p
- Subject
- Language
- ISSN
- 01406736; 1474547X